{"schema_version":"secwatch.filing_event.v1","accession":"0000721371-23-000035","form_type":"8-K","ticker":"CAH","cik":"0000721371","company_name":"CARDINAL HEALTH INC","filed_at":"2023-06-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.059781+00:00","generated_at":"2026-06-14T05:22:55.291573+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cardinal Health raises FY2023 EPS outlook, provides FY2024 guide of $6.45-$6.70, $3.5B buyback","bullets":["Narrows FY2023 non-GAAP EPS guidance to $5.65-$5.80 (mid-point 13% growth); preliminary FY2024 guidance $6.45-$6.70 (15% growth).","Long-term target: 12%-14% non-GAAP EPS CAGR over FY2024-2026; Pharmaceutical segment profit growth 4%-6%.","Board approves new $3.5B share repurchase authorization through 2027; plans at least $2B in buybacks over next three years.","Launches Navista Network for community oncology; retains and invests in Nuclear & Precision Health Solutions.","Medical Improvement Plan targets $650M+ segment profit by FY2026; $400M expected in FY2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000721371-23-000035","json":"https://secwatch.observer/filing/0000721371-23-000035.json","markdown":"https://secwatch.observer/filing/0000721371-23-000035.md","text":"https://secwatch.observer/filing/0000721371-23-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/721371/000072137123000035/0000721371-23-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/721371/000072137123000035/cah-20230608.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T05:22:55.291573+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}